Intracameral more effective than subconjunctival cefuroxime

Article

Intracameral cefuroxime is a safe alternative to subconjunctival cefuroxime and leads to a lower rate of endophthalmitis, claims a study published in the March 2008 issue of the Journal of Cataract & Refractive Surgery.

Intracameral cefuroxime is a safe alternative to subconjunctival cefuroxime and leads to a lower rate of endophthalmitis, claims a study published in the March 2008 issue of the Journal of Cataract & Refractive Surgery.

Patrick Yu-Wai-Man and colleagues at the Sunderland Eye Infirmary, UK, performed a retrospective analysis of all presumed infectious endophthalmitis cases from January 1, 2000, to December 31, 2006, and compared the rate of presumed infectious endophthalmitis in patients receiving subconjunctival cefuroxime with those receiving intracameral cefuroxime at the end of surgery.

The study, whose purpose was to compare the efficacy of intracameral cefuroxime versus subconjunctival cefuroxime in reducing the rate of endophthalmitis after cataract surgery, included 36 743 phacoemulsification cataract procedures, with a mean rate of presumed infectious endophthalmitis of 0.95 per 1000 cases. The incidence of endophthalmitis was significantly higher in the subconjunctival cefuroxime group than in the intracameral cefuroxime group.

Overall, the researchers found that intracameral cefuroxime was a safe alternative to subconjunctival cefuroxime and led to a lower rate of endophthalmitis.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jay Chhablani, MD, shares late-breaking data from the ArMaDa trial, investigating gene therapy for Geographic Atrophy and dry age-related macular degeneration, at EURETINA
Editorial advisory board member Alexandra Miere, MD, PhD, speaks about the ACTOR and HERMES studies at the 2025 European Society of Retina Specialists (EURETINA) Congress
María Berrocal, MD, speaks about the Vit-Buckle Society symposium hosted at the 2025 European Society of Retina Specialists (EURETINA) annual meeting
© 2025 MJH Life Sciences

All rights reserved.